Actavis to boost tablet capacity; and looking at RatiopharmIcelandic generics firm Actavis says expansion of its tablet plant will boost production capacity 50 per cent and create 50 new jobs. ISCO stem cell production site passes building inspectionISCO’s stem cell manufacturing facility has passed final building inspection, enabling it to implement the processes and cGMP standards needed to produce clinical-grade products. Pharmadule targets China with Morimatsu accordPharmadule has teamed up with Morimatsu to capture a share of Chinese pharma and biotech manufacturing markets’ “huge potential.” Pfizer, Roche and GSK report 2009 resultsIn a busy week of Big Phama results Pfizer reports sales boost from Wyeth, Roche says Genentech hit profits and GSK unveils surge in Relenza sales and plans to expand R&D restructuring. |
News in brief
|
|
Integrated solutions are the future of trial data management according to Phase Forward as growth of the electronic data capture (EDC) market begins to slow.
BioClinica is providing Cephalon with end-to-end clinical data management services and hiring some of the biotech’s staff under a three-year, multi-million dollar deal.
Gorbec Pharmaceutical Services is opening a GMP compliant analytical laboratory in Yantai, China to improve the service it offers to US-based clients and expand its presence in Asia.
Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.
|
|
Globalisation
More news |
|
|
Lifecycle management
More news |
|
|
Counterfeiting
More news |
|
|
Mergers and acquisitions
More news |
Nanotechnology safety legislation designed to address potential health and safety risks posed by the technology has been introduced to the US Senate...